The TERT promoter mutation, widespread in many malignancies including BCs, glioblastomas, melanoma, thyroid carcinoma (TC), and others, creates de novo ETS-binding motifs through which the GABP complex promotes TERT transcription and subsequent telomerase activation in these mutation-carrying tumors [24, 25]. The gene discussed is TERT; the disease is thyroid gland carcinoma.